EDGAR Filing Documents for 0001047469-03-005080

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]

SEC Accession No. 0001047469-03-005080

Filing Date

2003-02-13

Accepted

2003-02-12 20:07:57

Documents

Group Members

BIOTECHNOLOGY VALUE FUND II, L.P.BVF INC.BVF INVESTMENTS, L.L.C.BVF PARTNERS L.P.

Document Format Files

Seq	Description	Document	Type	Size
1	SC 13G/A	a2103179zsc13ga.htm	SC 13G/A	79785
3	EXHIBIT 99.1	a2103179zex-99_1.htm	EX-99.1	10869
	Complete submission text file	0001047469-03-005080.txt		92927

Mailing Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606

Business Address 227 W MONROE STREET, SUITE 4800 227 W MONROE STREET, SUITE 4800 CHICAGO IL 60606 415-288-23

BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE
SIC: 6282 Investment Advice

Mailing Address

Business Address PARC CLUB DU MOULIN A VENT 33 AVE DU DOCTEUR GEORGES LEVY VENISSIEUX CED I0 69693 2126641666

FLAMEL TECHNOLOGIES SA (Subject) CIK: 0001012477 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-50223 | Film No.: 03556478
SIC: 2834 Pharmaceutical Preparations